PKCα inhibitors promote breast cancer immune evasion by maintaining PD-L1 stability

被引：0
|
作者：
Yu, Jiaojiao [1 ]
Xiang, Yujin [1 ]
Gao, Yuzhen [1 ]
Hua, Fang [1 ]
Zhang, Xiaowei [1 ]
Li, Pingping [1 ]
Cui, Bing [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Beijing, Peoples R China
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0437
引用
收藏
页码：771 / 772
页数：2
相关论文
共 50 条
  • [21] Cancer immune evasion through KRAS and PD-L1 and potential therapeutic interventions
    Watterson, Alex
    Coelho, Matthew A.
    CELL COMMUNICATION AND SIGNALING, 2023, 21 (01)
  • [22] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
    Iosune Baraibar
    Ignacio Melero
    Mariano Ponz-Sarvise
    Eduardo Castanon
    Drug Safety, 2019, 42 : 281 - 294
  • [23] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
    Baraibar, Iosune
    Melero, Ignacio
    Ponz-Sarvise, Mariano
    Castanon, Eduardo
    DRUG SAFETY, 2019, 42 (02) : 281 - 294
  • [24] Progress of PD-1/PD-L1 immune checkpoint inhibitors in the treatment of triple-negative breast cancer
    Hongshu Li
    Ying Chang
    Tiefeng Jin
    Meihua Zhang
    Cancer Cell International, 25 (1)
  • [25] Glycolytic enzyme HK2 promotes PD-L1 expression and breast cancer cell immune evasion
    Lin, Jichun
    Fang, Wenshuo
    Xiang, Zhuo
    Wang, Qingqing
    Cheng, Huapeng
    Chen, Shimin
    Fang, Jing
    Liu, Jia
    Wang, Qiang
    Lu, Zhimin
    Ma, Leina
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [26] Echinacoside inhibits tumor immune evasion by downregulating inducible PD-L1 and reshaping tumor immune landscape in breast and colorectal cancer
    Wang, Xiaoyu
    Tan, Binxin
    Liu, Jiazhou
    Wang, Jing
    Chen, Mingjing
    Yang, Qian
    Zhang, Xiang
    Li, Fan
    Wei, Yuxian
    Wu, Ke
    Ren, Guosheng
    Li, Hongzhong
    PHYTOMEDICINE, 2024, 135
  • [27] PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
    Hartkopf, Andreas D.
    Taran, Florin-Andrei
    Wallwiener, Markus
    Walter, Christina B.
    Kraemer, Bernhard
    Grischke, Eva-Maria
    Brucker, Sara Y.
    BREAST CARE, 2016, 11 (06) : 385 - 390
  • [28] PD-1/PD-L1 expression in colorectal cancer and its implications for apoptosis and tumor immune evasion
    Gasser, Martin
    Grimm, Martin
    Nichiporuk, Ekaterina
    Bueter, Marco
    Lutz, Jens
    Lebedeva, Tatiana
    Koenigshausen, Matthias
    Thalheimer, Andreas
    Thiede, Arnulf
    Heemann, Uwe
    Meyer, Detlef
    Waaga-Gasser, Ana Maria
    CANCER RESEARCH, 2006, 66 (08)
  • [29] Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
    Wang, Yiting
    Shi, Hubing
    Meng, Huan
    Xu, Jie
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [30] Targeting the PD-1/PD-L1 immune evasion axis with DNA aptamers
    Prodeus, Aaron
    Gariepy, Jean
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
12345